Skip to content
Subscriber Only

Aspirin Cuts Pancreatic Cancer Risk by Half, Study Finds

Regular aspirin use cut the risk of pancreatic cancer by half, according to a finding that adds one of the most lethal malignancies to the list of diseases the inexpensive pill may help fight.

Men and women who took low-dose, about 75 to 325 milligrams, of aspirin daily, usually to prevent heart disease, had a 48 percent lower risk of pancreatic cancer, according to research published today in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. Taking aspirin regularly for a decade cut the risk by 60 percent.